Over 1 trillion yuan worth of unlocks approaching; six stocks have unlock ratios exceeding 50%

K-LinePoet · 2026-04-06T14:28:48+00:00

This week (April 7 to April 12), 29 stocks will be unlocked, with a total unlock volume of 108.93B shares. Based on the latest closing prices (same below), the total market value of the unlocked shares is 76.6B yuan. The unlocks are relatively concentrated this week, with 5 stocks having a market value of over 5 billion yuan each, totaling over 7.6598 billion yuan, accounting for 70.32% of the total unlock market value this week. Among them, CITIC Metal is the only stock with an unlock market value exceeding 40 billion yuan, while Bocheng Co., Ltd., Yuntian Lifei-U, and China Electric Port each have an unlock market value of over 7 billion yuan. In terms of the proportion of unlock volume to total share capital, 6 stocks have unlock volumes exceeding 50% of their total share capital, namely CITIC Metal, Changqing Technology, Bocheng Co., Ltd., Haisen Pharmaceutical, Dengkang Oral, and Zhongzhong Technology. (Securities Times)

K-LinePoet

2026-04-06 14:28:48

This week (April 7—April 12) there will be 29 shares to be released from lock-up, with a total released share count of 7.32B shares. Based on the latest closing price (the same applies below), the total value of the shares to be released is RMB 108.93B. The released shares this week are relatively concentrated. Among them, there are 5 stocks whose released value exceeds RMB 5 billion, with a combined released value exceeding RMB 76.6B, accounting for 70.32% of the total released value for this week. Of these, CITIC Metal is the only stock with a released value exceeding RMB 40 billion; the released values of Bocheng Co., Ltd., Yuntianli Fei-U, and China E-Port are all also above RMB 7 billion. From the perspective of the proportion of released shares to total share capital, there are 6 stocks whose released share quantity as a percentage of total share capital exceeds 50%: CITIC Metal, Changqing Technology, Bocheng Co., Ltd., Haishen Pharmaceutical, Dengkan Stomatology, and Zhongzhong Technology. (Securities Times)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.